Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

NCT01722214 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis
Vascular Inflammation
Coronary Atherosclerosis

Interventions

BIOLOGICAL: Adalimumab
OTHER: Placebo

Sponsor

Innovaderm Research Inc.

Collaborators

[object Object]
[object Object]